Six months after beginning its publishing journey, the Nexus of Pathophysiology & Therapeutics (NPT) has continued to build its scientific and editorial foundations, with the development of a growing and internationally represented Editorial Board.
NPT is pleased to announce that its Editorial Board has expanded to 27 members, bringing together researchers and academic experts with diverse backgrounds across pharmacology, clinical pharmacology, therapeutics, cardiology, pathology, toxicology, pharmaceutical biotechnology, medical biology, surgery, natural sciences, and related biomedical disciplines.
The journal's international editorial community currently brings together members from institutions across 10 countries, including Iran, the United States, Georgia, Türkiye, the Netherlands, France, Italy, China, India, and Sri Lanka.
This international composition reflects NPT's commitment to bringing together scientific expertise from different institutions, disciplines, and geographical regions. The Editorial Board includes established researchers alongside emerging academic experts, creating a multidisciplinary network to support the journal's peer-review and scientific activities.
Over its first six months, NPT has continued to develop its editorial infrastructure, expand its scientific network, and establish the foundations for a rigorous and internationally oriented publishing platform.
We are grateful to all members of the Editorial Board for their time, expertise, and commitment to supporting the development of NPT.
Six months in, the journey continues — with a growing scientific community and a shared commitment to rigorous biomedical research.
